Crossmark

Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00262-022-03173-w

Published Online: 2022-03-12

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Hongyu

Liu, Zilong

Wen, Haoyu

Guo, Yifan

Xu, Fengkai

Zhu, Qiaoliang

Yuan, Wei

Luo, Rongkui

Lu, Chunlai

Liu, Ronghua

Gu, Jie

Ge, Di https://orcid.org/0000-0001-5241-1766
Funding

Funding for this research was provided by:

Science and Technology Commission of Shanghai Municipality (20ZR1410800)

Science and Technology Commission of Shanghai Municipality (19QA1406900)
License Information

Text and Data Mining valid from 2022-03-12

Version of Record valid from 2022-03-12
More Information

Article History

Received: 27 October 2021

Accepted: 10 February 2022

First Online: 12 March 2022

Declarations

:

: The authors declare no potential conflict of interest.

: This study was approved by the Ethics Committee of the Clinical Research Ethics Committee of Zhongshan Hospital, Fudan University (B2021-128, HGBB-202105003). Written informed consent was obtained from each patient.

Document is current

Any future updates will be listed below